LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 88.84 | 27.76 | 12316 | 6965 | 1.7683 | 1.1483 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 90.55 | 27.76 | 4260 | 6928 | 0.6148 | 0.8815 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 90.55 | 27.76 | 8508 | 6928 | 1.2279 | 1.0522 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 90.55 | 27.76 | 1191 | 6928 | 0.1719 | 0.6032 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 90.55 | 27.76 | 12569 | 6928 | 1.8140 | 1.1553 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 92.25 | 27.76 | 3037 | 6873 | 0.4419 | 0.8048 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 92.25 | 27.76 | 8512 | 6873 | 1.2384 | 1.0545 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 92.25 | 27.76 | 1218 | 6873 | 0.1772 | 0.6089 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 92.25 | 27.76 | 12814 | 6873 | 1.8643 | 1.1630 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 93.96 | 27.76 | 1905 | 6849 | 0.2781 | 0.7025 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 93.96 | 27.76 | 8569 | 6849 | 1.2511 | 1.0572 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 93.96 | 27.76 | 1259 | 6849 | 0.1838 | 0.6161 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 93.96 | 27.76 | 13145 | 6849 | 1.9192 | 1.1710 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 95.66 | 27.76 | 1327 | 6712 | 0.1977 | 0.6297 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 95.66 | 27.76 | 8608 | 6712 | 1.2824 | 1.0638 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 95.66 | 27.76 | 1072 | 6712 | 0.1597 | 0.5864 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 95.66 | 27.76 | 13427 | 6712 | 2.0003 | 1.1830 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 1.95 | 27.76 | 675 | 225 | 2.9981 | 1.8770 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 1.95 | 27.76 | 596 | 225 | 2.6472 | 1.7608 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 3.66 | 27.76 | 740 | 283 | 2.6063 | 1.6610 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 3.66 | 27.76 | 681 | 283 | 2.3985 | 1.5959 | MN20160318_Q01 | M15 |